Clinical Trial Update: A Safety and Efficacy Study of BCD-021 With Paclitaxel and Carboplatin Compared to Avastin With Paclitaxel and Carboplatin in Non-Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing BCD-021 with paclitaxel and carboplatin to Avastin with paclitaxel and carboplatin in non-small cell lung cancer has completed with post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Avastin (bevacizumab)
• BCD-021

Snippet

Sponsor: Biocad | Conditions: Non-small Cell Lung Cancer | Phase 3 | Status: COMPLETED | Results posted: 2016-10-24